Adalimumab Clearance, Rather Than Trough Level, May Have Greatest Relevance to Crohn's Disease Therapeutic Outcomes Assessed Clinically and Endoscopically.
J Crohns Colitis
; 18(2): 212-222, 2024 Feb 26.
Article
em En
| MEDLINE
| ID: mdl-37594369
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Doença de Crohn
/
Adalimumab
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article